Orchard Therapeutics Plc - Company Profile

Powered by

All the data and insights you need on Orchard Therapeutics Plc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Orchard Therapeutics Plc Strategy Report

  • Understand Orchard Therapeutics Plc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Orchard Therapeutics Plc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Orchard Therapeutics Plc (Orchard Therapeutics), a subsidiary of Kyowa Kirin Co Ltd, is a pharmaceutical company that develops gene therapies for the treatment of rare diseases. The company’s product pipeline includes OTL-101, OTL-102, OTL-103, OTL-104, OTL-105, OTL-200, OTL-201, OTL-203 and OTL-204. Its pipeline treats adenosine deaminase, chronic granulomatous disease, wiskott aldrich syndrome, crohn disease, hereditary angioedema, mucopolysaccharidosis type I and mucopolysaccharidosis type IIIA, Orchard Therapeutics carries out strimvelis and libmeldy gene therapy for immunodeficiency and metachromatic leukodystrophy. It works in collaboration with The University of Manchester, Boston Children’s Hospital and San Raffaele Hospital. The company has operations in France, Germany, Italy, Switzerland, the Netherlands, the US and the UK. Orchard Therapeutics is headquartered in London, England, the UK.

 Gain a 360-degree view of Orchard Therapeutics Plc and make more informed decisions for your business Gain a 360-degree view of Orchard Therapeutics Plc and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address 3rd Floor, 245 Hammersmith Road, London, England, W68PW
Website www.orchard-tx.com
Telephone 44 20 38088286
No of Employees 166
Industry Pharmaceuticals and Healthcare
Revenue (2022) $22.7M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Orchard Therapeutics Plc premium industry data and analytics

30+

Catalyst Calendar

Proactively evaluate Orchard Therapeutics Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Clinical Trials

Determine Orchard Therapeutics Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

16+

Pipeline Drugs

Identify which of Orchard Therapeutics Plc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Sales & Consensus Forecasts

Understand the current and future drug revenue for Orchard Therapeutics Plc and assess market opportunity for new entrants with patient population 8-year forecasts.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Marketed Drugs

Understand Orchard Therapeutics Plc’s commercialized product portfolio to stay one step ahead of the market.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Pipeline Strimvelis
OTL-101 - Adenosine Deaminase Libmeldy
OTL-102 - Chronic Granulomatous Disease
XYZ
XYZ
XYZ
Understand Orchard Therapeutics Plc portfolio and identify potential areas for collaboration Understand Orchard Therapeutics Plc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Orchard Therapeutics Plc Oxford BioMedica Plc Silence Therapeutics Plc Mission Therapeutics Ltd Phynova Group Ltd
Headquarters United Kingdom United Kingdom United Kingdom United Kingdom United Kingdom
City London Oxford London Cambridge Banbury
State/Province England England England England England
No. of Employees 166 714 116 45 7
Entity Type Private Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Hubert Baburaj, Gaspar Managing Executive Officer; Director Executive Board 2018 61
Abdul Hafeez, Mullick Management Executive Officer; Director Executive Board 2024 57
Takeyoshi Yamashita Director; Senior Management Executive Officer Executive Board 2024 63
Bobby Gaspar, M.D., Ph.D. Chief Executive Officer Senior Management - -
Frank Thomas President; Chief Operating Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Orchard Therapeutics Plc key executives to enhance your sales strategy Gain insight into Orchard Therapeutics Plc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer